N.S. Abdelhamid / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 233 (2020) 118213
3
2.2. Instruments
against the concentrations (μg/mL) to obtain linear calibration curves
and the regression equations were computed.
A UV lamp with short wavelength 254 nm (USA) and a double beam,
UV–visible spectrophotometer (SHIMADZU, Japan) model UV-1601 PC
with quartz cells of 1 cm path length, connected to IBM compatible com-
puter. The software was UVPC personal spectroscopy software version 3.7.
2.4.2. Analysis of laboratory prepared mixtures of PC, DH, PAP and NOD
Mixtures containing different concentrations of PC, DH, PAP and NOD
were analyzed by applying the above described procedure “Table 1”.
2.3. Prepared solutions
2.4.3. Application to pharmaceutical formulation; Panadol night ® tablets
Ten tablets were weighed, powdered and mixed well. An accurately
weighed portion of the powdered tablets equivalent to 100 mg of PC
and 5 mg of DH was transferred into 100-mL volumetric flask; dissolved
by sonication for 30 min with 75 mL of methanol, completed to volume
with the same solvent, and then filtered. Ten mL of the above solution is
diluted with methanol in 100mL volumetric flask to obtain a working
solution of the dosage form containing 100 μg/mL of PC and 5 μg/mL
of DH. From the prepared working solution, a volume of 4 mL is accu-
rately transferred into 10-mL volumetric flask and the volume is com-
pleted with methanol to obtain a solution of the tablets in which PC
concentration is 40μg/mL and DH concentration is 2μg/mL. The same
procedure for TD-RD and DD-RD-DW methods were applied, where
the concentrations of PC and DH in the tablets were calculated from
the corresponding regression equations.
2.3.1. Standard solutions
For stock standard solutions containing 1 mg/mL; 0.1 g of each of the
four components was accurately weighed into a separate 100 mL volu-
metric flask; dissolved in 50 mL of methanol and shaken to dissolve, and
then the volume was completed with methanol. For working standard
solutions containing 100 μg/mL, aliquots of 10 mL of each stock standard
solution were transferred into four separate 100 mL volumetric flasks,
and then the volume was completed with methanol.
2.3.2. Laboratory prepared mixtures
Mixtures containing different ratios of four components were pre-
pared using their working solutions in methanol. The concentrations
of the four components in different mixtures are shown in Table 1.
N.B. The determination was done at room temperature and the spec-
trophotometric measurements were performed using scaling factor
equals 1 and Δλ equals 2.
2.4. Methodology
2.4.1. Linearity and construction of calibration curves
For TD-RD spectrophotometric method, the ratio spectra of different
concentrations of each drug were obtained by dividing the absorption
spectra by the normalized spectrum of a ternary mixture containing
equal concentrations (40 μg/mL) of the 3 interfering components. Two
wavelengths were selected in the ratio spectrum of each drug to
achieve a high amplitude difference. The selected wavelengths were
(256–290 nm), (220–230 nm), (230–245 nm) and (275–260 nm) for
PC, DH, PAP and NOD, respectively. The amplitude differences between
the 2 selected wavelengths in the ratio spectra of each drug were plot-
ted against the concentrations (μg/mL) to obtain linear calibration
curves and the regression equations were computed.
3. Results and discussion
3.1. Method development and optimization
The zero order absorption spectra of PC, DH, PAP and NOD show se-
vere overlap which hinders the use of direct spectrophotometry for the
simultaneous determination of the four compounds as shown in Fig. 3.
The aim of this work is to establish and validate spectrophotometric
methods which can easily resolve this overlap.
For DD-RD-DW spectrophotometric method, the ratio spectra of dif-
ferent concentrations of each drug were obtained by dividing the absorp-
tion spectra by the normalized spectrum of a binary mixture containing
equal concentrations (40 μ/mL) of two of the interfering components.
The used double divisors were DH/NOD mixture for PC and PAP, and
PC/PAP mixture for DH and NOD. Two wavelengths were selected in
the ratio spectra where the drug of interest gives considerable ampli-
tude difference, while the third interfering component gives zero am-
plitude difference. The selected wavelengths were (243–233 nm),
(223.8–270.2 nm), (237–250 nm) and (265–234.6 nm) for PC, DH,
PAP and NOD, respectively. The amplitude differences between the 2 se-
lected wavelengths in the ratio spectra of each drug were plotted
3.1.1. Double divisor – ratio difference – dual wavelength (DD-RD-DW)
spectrophotometric method
DD-RD-DW spectrophotometric method depends on dividing the
absorption spectrum of the quatertnary mixture by a double divisor
consisting of the normalized spectrum of a binary mixture of two of
the interfering components. Thus, these two interfering compounds
give constant amplitude all over the whole spectrum. In the ratio spec-
trum, two wavelengths are chosen at which the third interfering com-
ponent give equal amplitudes, such that the difference between the
amplitudes between these two wavelengths depends only on the con-
centration of one component, as these steps have been able to solve
the interference of the other three components.
Table 1
The simultaneous determination of paracetamol (PC), diphenhydramine (DH), p-aminophenol (PAP) and N-oxide degradate of diphenhydramine (NOD) in laboratory prepared mixtures
using DD-RD-DW and TD-RD.
Mixture Ratio % of degradation
Taken (μg/mL)
Recovery % obtained by DD-RD-DW
Recovery % obtained by TD-RD
PC:
DH
products
PC
25
DH PAP NOD PC
DH
PAP
NOD
PC
DH
PAP
NOD
1
2
3
4
5
6
7
1:2
1:2
1:1
2:1
2:1
2
2
5
10
20
50
0.5
2
1
4
99.323
–
100.822
–
–
98.286
99.929
100.286
98.857
99.214
99.714
101.269
99.651
0.982
98.983
–
100.786
–
–
98.153
99.876
100.154
98.754
99.456
99.342
101.134
99.553
0.968
100 200
98.947
–
98.851
–
20
40
40
40
40
20
20
20
2
1
4
8
20
36
1
2
4
1
99.935
100.641
100.542
101.115
101.051
100.657
0.690
101.833
99.796
100.389
101.852
99.944
100.763
0.903
99.875
100.562
100.653
101.097
100.843
100.336
0.779
101.687
99.951
100.451
101.768
99.874
100.753
0.826
100.263
101.250
99.763
97.763
99.597
1.321
100.103
101.390
99.540
97.901
99.557
1.313
20:1a 50
2:1
SD
90
20
18
Mean
a
The ratio present in Panadol night® tablets.